Molecular Analysis of the Cyclin-dependent Kinase Inhibitor Gene p27/Kip1 in Human Malignancies

Cancer Research

Volumn 55, Issue 11, 1995, Pages 2266-2269

  Kawamata, Norihiko ^a   Morosetti, Roberta ^a   Miller, Carl W ^a   Park, Dorothy ^a   Spirin, Konstantin S ^a   Nakamaki, Tsuyoshi ^a   Takeuchi, Seisho ^a   Hatta, Yoshihiro ^a   Simpson, Jean ^b   Wilczynski, Sharon ^b   Lee, Young Yiul ^c   Bartram, Claus R ^d   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c Hanyang University   (South Korea)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; GLYCINE; GUANINE; PROTEIN KINASE INHIBITOR; THYMINE; VALINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ARTICLE; CANCER; CELL CYCLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; GENE MUTATION; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MOLECULAR GENETICS; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; SARCOMA; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; STOMACH CANCER; TESTIS CANCER; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

BASE SEQUENCE; BLOTTING, SOUTHERN; CYCLIN-DEPENDENT KINASES; FEMALE; HUMAN; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029007867     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sherr, C. J. Mammalian Gl cyclins. Cell, 73:1059–1065, 1993.
2. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366:704–707, 1993.
3. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368:753–756, 1994.
4. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264:436–440, 1994.
5. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211:90–98, 1994.
6. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366:701–704, 1993.
7. El-Deiry, W., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75:815–825, 1993.
8. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell, 75:805–816, 1993.
9. Hannon, G. J., and Beach, D. p15INK4B is a potential effector of TGF-0-induced cell cycle arrest. Nature (Lond.), 371:257–261, 1994.
10. Jen, J., Harper, W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54:6353–6358, 1994.
11. Guan, K-L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., and Xiong, Y. Growth suppression by p18, a p16INK4/MTSl- and p14INK4B/ MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8:2939–2952, 1994.
12. Hunter, T. Braking the cycle. Cell, 75:839–841, 1993.
13. Serrano, M., Gomez-Lahoz, E., DePinho, R. A., Beach, D., and Bar-Sagi, D. Inhibition of Ras-induced proliferation and cellular transformation by p16INK4. Science (Washington DC), 267:249–252, 1995.
14. Imamura, J., Miyoshi, I., and Koeffler, H. P. p53 in hematological malignancies. Blood, 84:2412–2421, 1994.
15. Prokocimer, M., and Rotter, V. Structure and function of p53 in normal cells and their aberrations in cancer cells:projection on the hematological cell lineages. Blood, 84:2391–2411, 1994.
16. Polyak, K., Lee, M-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J. Cloning of p27/kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78:59–66, 1994.
17. Toyoshima, H., and Hunter, T. p27, a novel inhibitor of Gl cyclin-cdk protein kinase activity, is related to p21. Cell, 78:61–64, 1994.
18. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., and Araheim, N. Enzymatic amplification of 0-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (Washington DC), 230:1350–1354, 1985.
19. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning:A Laboratory Manual, Cold Spring Harbor, NY:Cold Spring Harbor Laboratory, 1989.
20. Shiohara, M., El-Deiry, W. S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D-L., Vogelstein, B., and Koeffler, H. P. Absence of WAF1 mutations in a variety of human malignancies. Blood, 84:3781–3784, 1994.
21. Breathnach, R., and Chambon, P. Organization and expression of eucaryotic split genes coding for proteins. Annu. Rev. Biochem., 50:349–383, 1981.
22. Mori, T., Miura, K., Aoki, T., Nishihara, T., Mori, S., and Nakamura, Y. Frequent somatic mutation of the CDKN2/CDK4I (multiple tumor suppressor/cyclin-depend-ent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54:3396–3397, 1994.
23. Hayashi, N., Sugimoto, Y., Tsuchiya, E., Ogawa, M., and Nakamura, Y. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4I (cyclin-dependcnt ki-nase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem. Biophys. Res. Commun., 202:1426–1430, 1994.
24. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Beymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. Frequent somatic mutations and homozygous deletions of the pi6 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8:27–32, 1994.
25. Xu, L., Sgroi, D., Sterner, C. J., Beauchamp, R. L., Pinney, D. M., Keel, S., Ueki, K., Rutter, J. L., Buckler, A. J., Louis, D. N., Gusella, J. F., and Ramesh, V. Mutational analysis of CDKN2 (MTSl/p16lnk4) in human breast carcinomas. Cancer Res., 54:5262–5264, 1994.
26. Ueki, K., Rubio, M-P., Ramesh, V., Correa, K. M., Rutter, J. L., von Deimling, A., Buckler, A. J., Gusella, J. F., and Louis, D. N. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum. Mol. Genet., 3:1841–1845, 1994.
27. Gu, Y., Turck, C. W., and Morgan, D. O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366:707–710, 1993.
28. Jiang, H., and Fisher, P. B. Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol. Cell. Differ., 7:285–299, 1993.